Naiyer A. Rizvi

Oncology

1275 York Ave
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project.

Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 25, 2025

Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project.

Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 25, 2025

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 01, 2025

Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.

Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.

Journal: RMD open

Published: May 01, 2025

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Journal: Nature

Published: February 27, 2025

Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings.

Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings.

Journal: Journal for immunotherapy of cancer

Published: October 05, 2024

Lung cancer research and treatment: global perspectives and strategic calls to action.

Lung cancer research and treatment: global perspectives and strategic calls to action.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 09, 2024

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab.

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab.

Journal: Nature medicine

Published: November 07, 2023

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Journal: Nature

Published: October 27, 2023

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development.

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development.

Journal: Journal for immunotherapy of cancer

Published: June 28, 2023

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 16, 2023

Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.

Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.

Journal: Nature medicine

Published: January 24, 2023

Showing 1-12 of 106

Last Updated: 09/26/2026